20Jul 2017

SAFETY OF ONCOPLASTIC REDUCTION MAMMOPLASTY: FIVE-YEARS TERTIARY CARE CENTER EXPERIENCE.

  • Researcher, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
  • College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Department of Plastic Surgery, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Department of General Surgery, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Oncoplastic reduction mammoplasty (ORM) had expanding the role of breast conserving surgery (BCS). However, concerns regarding the oncological safety of this procedure have been expressed. The purpose of this study was to evaluate the safety of (ORM) surgery in King Abdulaziz Medical City (KAMC). Methods: Breast cancer patients treated with ORM between 2010 and 2015 were included. Patients? demographics and clinical outcomes including, the location and histological characteristic of breast cancer, types of breast reduction techniques, tumor margin positivity and history characteristics were queried. Results: The study included fifteen patients the mean age was 47 years with SD 9.1. There were no mortalities or major complications other than positive margin after the surgery. Right breast cancer was the most common 67%. Invasive Ductal Carcinoma (IDC) was the commonest type 80%. The pathological stage ypT1N0Mx was the most common 46 % and the pathological Grade 3 was the most common grade overall 67%. The tumor size range from 4 mm to 50 mm with mean 26.41 mm and SD 17.15. The inferior pedicle breast reduction was the most common technique account for 67%. The majority of patients (87%) did not require any further breast surgery. However, two patients (13%) of all cases required further breast surgery after the ORM. Conclusions: Our experience with ORM showed that it is a safe and reliable procedure with better cosmetic outcome in our population. Further multicenter study including larger sample size in Saudi Arabia is necessary.


  1. Hunt Kelly K, Robertson John F.R. The Breast.? In: Brunicardi F Charles et al.? Schwartz?s principles of surgery.? 10th Ed.? New York: McGraw-Hill Education; 2015.? 497- 564.
  2. Gabka CJ,?Maiwald G,?Baumeister RG. Expanding the indications spectrum for breast saving therapy of breast carcinoma by oncoplastic operations. Langenbecks Arch Chir Suppl Kongressbd 1997 114: 1224-7. [Article in German]
  3. Baildam,A.D. Oncoplastic surgery for breast cancer. Br J Surg 2008 95:?4?5.
  4. Lucy Mansfield,?Avi Agrawal,?and?Ramsey I. Cutress. Oncoplastic breast conserving surgery.? Gland Surg 2013 2: 158-62.
  5. Morrow M. Minimally invasive surgery for breast cancer. BMJ. 2009;338:b557.
  6. Chakravorty A, Shrestha AK, Sanmugalingam N, et al. How safe is oncoplastic breast conservation? Comparative analysis with standard breast conserving surgery. Eur J Surg Oncol.?2012 38:395-8.
  7. Fitoussi AD, Berry M, Fama F, et al. Oncoplastic breast surgery for cancer: analysis of 540 consecutive cases [outcomes article]. Plast Reconstr Surg.. 2010;125(2):454-62.
  8. Goffman TE, Schneider H, Hay K, Elkins DE, Schnarrs RA, Carman C. Cosmesis with bilateral mammoreduction for conservative breast cancer treatment. Breast J.2005;11(3):195-8.
  9. Emiroglu M, Salimoglu S, Karaali C, et al. Oncoplastic reduction mammoplasty for breast cancer in women with macromastia: Oncological long-term outcomes. Asian J Surg. 2015.
  10. De La Cruz L, Blankenship SA, Chatterjee A, et al. Outcomes After Oncoplastic Breast-Conserving Surgery in Breast Cancer Patients: A Systematic Literature Review. Ann Surg Oncol. 2016;23(10):3247-58.
  11. Kronowitz SJ, Hunt KK, Kuerer HM, et al. Practical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conservation therapy.? Plast Reconstr Surg.?2007?120: 1755-6.
  12. Kaur N, Petit J-Y, Rietjens M, et al. Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancer. Ann Surg Oncol 2005;12(7):1?7.
  13. Losken A, Dugal CS, Styblo TM, Carlson GW. A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique. Ann Plast Surg. 2014;72(2):145-9.
  14. Meretoja TJ, Svarvar C, Jahkola TA. Outcome of oncoplastic breast surgery in 90 prospective patients. Am J Surg 2010;200(2):224?228.
  15. McCulley S, Macmillan R. Therapeutic mammaplasty?analysis of 50 consecutive cases. Br J Plast Surg. 2005;58(7):902-7.
  16. Brinton LA, Persson I, Boice JD Jr, McLaughlin JK, Fraumeni JF Jr. Breast cancer risk in relation to amount of tissue removed during breast reduction operations in Sweden. Cancer 2001;91(3): 478?483.
  17. Fernando IN, Ford HT, Powles TJ, et al. Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol). 1996 Dec 31;8(4):226-33.
  18. Iwuchukwu OC, Harvey JR, Dordea M, Critchley AC, Drew PJ. The role of oncoplastic therapeutic mammoplasty in breast cancer 
surgery?a review. Surg Oncol 2012;21(2):133?
  19. Rose JF, Colen JS, Ellsworth WAt. Reduction and Mastopexy Techniques for Optimal Results in Oncoplastic Breast Reconstruction. Semin Plast Surg. 2015;29(2):102-9.
  20. Pusic AL, Klassen AF, Cano SJ. Use of the BREAST-Q in clinical outcomes research. Plast Reconstr Surg. 2012 Jan 1;129(1):166e-7e.
  21. Chang E, Johnson N, Webber B, et al. Bilateral reduction mammoplasty in combination with lumpectomy for treatment of breast cancer in patients with macromastia. Am J Surg. 2004;187(5):647-51.
  22. Cochrane RA, Valasiadou P, Wilson AR, Al‐Ghazal SK, Macmillan RD. Cosmesis and satisfaction after breast‐conserving surgery correlates with the percentage of breast volume excised. Br J Surg. 2003 Dec 1;90(12):1505-9.

[Ali Hadadi, Obaid Almeshal, Manal Alzaid and Reem Aljehani. (2017); SAFETY OF ONCOPLASTIC REDUCTION MAMMOPLASTY: FIVE-YEARS TERTIARY CARE CENTER EXPERIENCE. Int. J. of Adv. Res. 5 (Jul). 1283-1292] (ISSN 2320-5407). www.journalijar.com


Ali Hadadi
MBBS

DOI:


Article DOI: 10.21474/IJAR01/4839      
DOI URL: http://dx.doi.org/10.21474/IJAR01/4839